全文获取类型
收费全文 | 10389篇 |
免费 | 459篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 161篇 |
儿科学 | 185篇 |
妇产科学 | 173篇 |
基础医学 | 1368篇 |
口腔科学 | 283篇 |
临床医学 | 712篇 |
内科学 | 2518篇 |
皮肤病学 | 176篇 |
神经病学 | 658篇 |
特种医学 | 335篇 |
外科学 | 1607篇 |
综合类 | 53篇 |
一般理论 | 2篇 |
预防医学 | 308篇 |
眼科学 | 199篇 |
药学 | 792篇 |
中国医学 | 13篇 |
肿瘤学 | 1336篇 |
出版年
2023年 | 45篇 |
2022年 | 93篇 |
2021年 | 183篇 |
2020年 | 94篇 |
2019年 | 114篇 |
2018年 | 131篇 |
2017年 | 124篇 |
2016年 | 146篇 |
2015年 | 136篇 |
2014年 | 188篇 |
2013年 | 292篇 |
2012年 | 442篇 |
2011年 | 481篇 |
2010年 | 258篇 |
2009年 | 281篇 |
2008年 | 446篇 |
2007年 | 508篇 |
2006年 | 476篇 |
2005年 | 537篇 |
2004年 | 519篇 |
2003年 | 509篇 |
2002年 | 503篇 |
2001年 | 370篇 |
2000年 | 357篇 |
1999年 | 323篇 |
1998年 | 167篇 |
1997年 | 130篇 |
1996年 | 109篇 |
1995年 | 111篇 |
1994年 | 104篇 |
1993年 | 76篇 |
1992年 | 256篇 |
1991年 | 234篇 |
1990年 | 251篇 |
1989年 | 236篇 |
1988年 | 200篇 |
1987年 | 167篇 |
1986年 | 155篇 |
1985年 | 151篇 |
1984年 | 93篇 |
1983年 | 91篇 |
1981年 | 52篇 |
1979年 | 68篇 |
1977年 | 39篇 |
1973年 | 54篇 |
1972年 | 51篇 |
1971年 | 48篇 |
1970年 | 43篇 |
1969年 | 71篇 |
1968年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
993.
994.
995.
996.
Shimada H Okazumi S Matsubara H Shiratori T Akutsu Y Nabeya Y Tanizawa T Matsushita K Hayashi H Isono K Ochiai T 《World journal of surgery》2008,32(2):255-261
Background Although thoracic lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma (SCC) has been reported
to be a negative risk factor for long-term survival, only a few studies have evaluated the clinicopathologic difference between
the impact of metastasis to the paraesophageal lymph nodes and to the nonparaesophageal lymph nodes. The purpose of this study
was to evaluate surgical outcome after the clearance of metastatic thoracic lymph nodes.
Methods Retrospectively reviewed were 164 consecutive patients with thoracic esophageal SCC who had not had preoperative treatment
and underwent surgery from 1980 to 2005 and were found to have thoracic lymph node metastases. Of these patients, 83 underwent
surgery from 1980 to 1994 and 81 from 1995 to 2005. Univariate and multivariate analyses were performed to evaluate the impact
of nonparaesophageal lymph node metastasis on survival.
Results Univariate analysis revealed that T3/T4 tumors and the presence of nonparaesophageal node metastases were associated with
only a 20% overall five-year survival rate. The overall five-year survival for the most recent period was significantly better
than for the former period (42% vs. 13%, p < 0.01). Based on a multivariate analysis of prognostic impact of each nonparaesophageal node, the presence of metastatic
subcarinal and/or posterior mediastinal nodes was an independent risk factor for reduced survival.
Conclusion Surgical outcome for patients with thoracic esophageal cancer and metastatic thoracic lymph nodes has improved during the
last 25 years. Although postoperative chemotherapy might improve survival, the presence of T3/T4 tumors and/or metastatic
nonparaesophageal nodes were unfavorable factors for survival. 相似文献
997.
Nagata S Funakosi S Amae S Yoshida S Ambo H Kudo A Yokota A Ueno T Matsuoka H Hayashi Y 《Journal of pediatric surgery》2008,43(8):1480-1486
Purpose
The aim of the study was to investigate posttraumatic stress disorder (PTSD) in mothers of children who have undergone surgery for congenital disease at a pediatric surgery department.Methods
A questionnaire survey was carried out in 145 mothers of children who had undergone surgery and were still alive. For comparison, the mothers were categorized into 3 groups according to the severity of their child's disease.Results
Of the 145 mothers, 29 (20%) were likely to be diagnosed as having developed PTSD at the time of the survey. Posttraumatic stress disorder symptoms correlated with factors such as anxiety and condition of the child. In terms of the disease severity of the child, factors such as anxiety tended to be observed more frequently in the higher disease severity group, whereas the proportion of mothers likely to be diagnosed as having developed PTSD was smallest in the moderate-severity group.Conclusions
Twenty percent of the mothers of children had probably developed PTSD. In the moderate-severity group, there seemed to be a factor that alleviated PTSD symptoms. Because mothers provided effective care for the symptoms of children in the moderate-severity group, this observation suggests that participation of the mother in their child's treatment might prevent them from developing PTSD symptoms. 相似文献998.
Cui Q Yu JH Wu JN Tashiro S Onodera S Minami M Ikejima T 《Acta pharmacologica Sinica》2007,28(7):1057-1066
Aim: To study the caspase-3-independent mechanisms in oridonin-induced MCF-7 human breast cancer cell apoptosis in vitro. Methods: The viability of oridonin- treated MCF-7 cells was measured by MTT (thiazole blue) assay. Apoptotic cells with condensed nuclei were visualized by phase contrast microscopy. Nucleosomal DNA fragmentation was assayed by agarose gel electrophoresis. The apoptotic ratio was determined by lactate dehydrogenase assay. Cell cycle alternation and mitochondrial membrane potential were measured by flow cytometric analysis. Bax, Bcl-2, caspase-3, caspase-9, heat shock protein (Hsp)90, p53, p-p53, p21, Poly (ADP-ribose) polymerase (PARP), and the inhibitor of caspase-activated DNase (ICAD) protein expressions were detected by Western blot analysis. Results: Oridonin inhibited cell growth in a time- and dose-dependent manner. Cell cycle was altered through the upregulation of p53 and p21 protein expressions. Pancaspase inhibitor Z-VAD-fmk and calpain inhibitor II both decreased cell death ratio. Nucleosomal DNA fragmentation and the downregulation of △ψmit were detected in oridonin-induced MCF-7 cell apoptosis, which was involved in a postmitochondrial caspase-9-dependent pathway. Decreased Bcl-2 and Hsp90 expression levels and increased Bax and p21 expression levels were positively correlated with elevated levels of phosphorylated p53 phosphorylation. Moreover, PARP was partially cleaved by calpain rather than by capase-3. Condusion: DNA damage provoked alternations in the mitochondrial and caspase-9 pathways as well as p53-mediated cell cycle arrest, but was not related to caspase-3 activity in oridonin-induced MCF-7 cells. 相似文献
999.
Okamoto H Watanabe K Kunikane H Yokoyama A Kudoh S Asakawa T Shibata T Kunitoh H Tamura T Saijo N 《British journal of cancer》2007,97(2):162-169
We compared the efficacy and the safety of a carboplatin plus etoposide regimen (CE) vs split doses of cisplatin plus etoposide (SPE) in elderly or poor-risk patients with extensive disease small-cell lung cancer (ED-SCLC). Eligibility criteria included: untreated ED-SCLC; age >/=70 and performance status 0-2, or age <70 and PS 3. The CE arm received carboplatin area under the curve of five intravenously (IV) on day 1 and etoposide 80 mg m(-2) IV on days 1-3. The SPE arm received cisplatin 25 mg m(-2) IV on days 1-3 and etoposide 80 mg m(-2) IV on days 1-3. Both regimens were given with granulocyte colony-stimulating factor support in a 21-28 day cycle for four courses. A total of 220 patients were randomised. Median age was 74 years and 74% had a PS of 0 or 1. Major grade 3-4 toxicities were (%CE/%SPE): leucopenia 54/51, neutropenia 95/90, thrombocytopenia 56/16, infection 7/6. There was no significant difference (CE/SPE) in the response rate (73/73%) and overall survival (median 10.6/9.9 mo; P=0.54). Palliation scores were very similar between the arms. Although the SPE regimen is still considered to be the standard treatment in elderly or poor-risk patients with ED-SCLC, the CE regimen can be an alternative for this population considering the risk-benefit balance. 相似文献
1000.